Intellectual Property attorneys Stephen Benson, Christopher Ferenc and Rachel Schweers will discuss recent developments in the biologics industry at 2:00 p.m. ET on Thursday, April 24. Topics will include:
- the President’s recent budget proposals surrounding illegal pay-for-delay agreements and seven-year exclusivity limits;
- the naming convention and patent term extension proposals; and
- the latest domestic and international biosimilar activity that is likely to influence the evolution of biologics in the United States.
To view a video recording of the webinar, click here.